Soluble CD146 Is a Novel Marker of Systemic Congestion in Heart Failure Patients: An Experimental Mechanistic and Transcardiac Clinical Study

Mattia Arrigo(University Hospital of Zurich), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Heli Tolppanen(Inserm), James L. Januzzi(Harvard University), Jane‐Lise Samuel(Université Paris Cité), Quynh A. Truong(Tufts Medical Center), Jackie Szymonifka(Cornell University), Malha Sadoune(Inserm), Étienne Gayat(Inserm), P.C. Colombo(Columbia University), Alain Cohen‐Solal(Inserm), Jean Marie Launay, Duygu Onat(Columbia University Irving Medical Center), Ryan T. Demmer(University of Minnesota), Ka Yuk Wong(Columbia University Irving Medical Center), Jagmeet P. Singh(Massachusetts General Hospital)
Clinical Chemistry
October 26, 2016
10.1373/clinchem.2016.260471
Cited by 48

Related Papers

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
|European Heart Journal|2008|2.7k